KRISTA PEMBROKE: Open Payments
NPI 1043920606 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 69 payments from 15 companies in 2025. Trend: 2023 $2,375 · 2024 $1,024 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $270 |
| ABBVIE INC. | 13 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $145 |
| Alkermes, Inc. | 6 | $109 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Tris Pharma Inc | 4 | $80 |
| Lundbeck LLC | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
Products named: Auvelity, VRAYLAR, CAPLYTA, ARISTADA, FANAPT, Dyanavel XR, REXULTI, Jornay PM.
Industry payments across VA — which companies pay providers there.
